29 Nov 2024
HKU Signs Agreement with China Merchants Group on Peptide Drug Innovation and Discovery to Pioneer Collaboration in Biopharmaceutical Research

(From back left) Mr. Pierre Wang, Managing Director of Versitech Limited, Professor Xuechen Li, Associate Dean of Science Faculty, Professor Qiang Zhou, Dean of Science Faculty, Professor Xiang Zhang, President of HKU, Mr. Jianmin Miao, Chairman of CMG, Mr. Renjie Deng, Executive Vice President, Mr. Junli Zhang, Assistant General Manager and Office Director, CMG, Mr. Changjiang Huang, General Manager of Tianjin Institute of Pharmaceutical Research Co., Ltd.
(From front left) Mr. Weidong Deng, General Manager of China Merchants Innovation Technology, Professor Max Shen, Vice President of HKU, Mr. Xiaohua Huang, General Manager of China Merchants Health Industry Holdings Co., Ltd. and Chairman of Tianjin Pharmaceutical Research Institute Co., Ltd.
The signing ceremony was held on the HKU campus, attended by Professor Xiang Zhang, President and Vice-Chancellor of HKU, and Mr. Jianmin Miao, Chairman of CMG. Other guests included Professor Max Shen, Vice President and Pro-Vice-Chancellor (Research); Professor Qiang Zhou, Dean of the Faculty of Science; Professor Chi-Ming Che, Laboratory Director of the State Key Laboratory of Synthetic Chemistry; Professor Xuechen Li, Associate Dean of the Faculty of Science, at HKU; Mr. Renjie Deng, Executive Vice President, and Mr. Junli Zhang, Assistant General Manager and Office Director, at CMG.
In his concluding speech, Professor Max Shen stated that this collaboration demonstrates China Merchants Group's commitment to innovative research. He expressed his anticipation for enhancing cooperation with China Merchants Group to promote further research. Professor Shen also envisions further collaboration between the University and the industry to drive innovation and entrepreneurship development in both Hong Kong and the Greater Bay Area.
China Merchants Group (CMG) is one of China’s centrally administrated state-owned enterprises and a key section of the backbone of the national economy. Founded and headquartered in Hong Kong, it was one of the earliest Chinese-funded enterprises to operate there. CMG is a century-old comprehensive and Hong Kong-based central enterprise.
Versitech Limited is the commercial arm of HKU. It was established in 1994 as a wholly-owned subsidiary of the University and is incorporated as a non-profit company with prominent business people on its Board of Management. Versitech negotiates, executes and manages commercial business contracts and agreements on behalf of the University. To serve business and community needs, Versitech undertakes the commercialisation of HKU innovations and technologies through licensing, the creation of start-ups or collaboration, and engages in contract research and consulting in conjunction with HKU researchers. Website: https://www.versitech.hku.hk.